Professional Documents
Culture Documents
Mcphie 2016
Mcphie 2016
Hospital Course
The infant had been transferred to our children’s hospi- Final Diagnosis
tal for evaluation of possible EB. The general pediatric The final skin biopsy results demonstrated subepidermal
service clinicians confirmed the suspected diagnosis blisters with no inflammation, compatible with EB.
and consulted the pediatric dermatology service. Our Further testing using immunomapping suggested the
consultant dermatologist favored a diagnosis of dystro- dystrophic form of EB, confirming the initial clinical
phic EB (DEB) based on the infant’s presenting physical impression. However, unexpectedly, the infant’s genetic
examination (i.e., skin involvement only) and results of testing revealed two mutations on the COL7A1 gene.
the initial skin biopsy. Mutations in the COL7A1 gene are associated with all
During the infant’s hospital admission, he had forms of DEB. The infant had a nonsense mutation
feeding difficulties as a result of severe ankyloglossia. (R669X), which is associated with recessive DEB, and
Bottle and breast feedings were creating patchy areas he had a missense mutation (G2245S), which had not
of erythema and ulceration on the infant’s inner lips previously been reported to be associated with DEB.
and hard palate. Otolaryngology specialists were con- The missense mutation was a glycine substitution for
sulted regarding the possibility of a frenotomy, but serine on exon 85. Because the nonsense mutation
correction was deferred to minimize complications was inherited recessively, it was concluded that the in-
fant actually demonstrated a recessive inheritance
pattern. Therefore, based on genetic testing, the infant
FIGURE 2. Raw dermal connective tissue present received a final diagnosis of recessive DEB (RDEB), not
in a stocking distribution. the initially presumed less-lethal dominant DEB
(DDEB).
DISCUSSION
EB refers to a heterogeneous group of inherited skin
disorders characterized by blister formation and skin
fragility. Although fairly distinct in presentation,
other conditions must also be considered during
evaluation. The differential diagnosis for EB is vast
and includes both infectious and noninfectious dis-
orders (Box 2).
The prevalence and incidence of EB in the United
States is approximately 19 per 1 million live births or 8
per 1 million population (Fine, 2010). The disorder af-
fects both genders equally and occurs in every racial
and ethnic group. With new national registries, the
This figure appears in color online at www.jpedhc. exact prevalence and incidence of this disease should
org. be better quantified in the future.
Organizations
Children’s Skin Disease Foundation: https://www.csdf.org
ClinicalTrials.gov: http://clinicaltrials.gov (offers up-to-date information for locating federally and privately supported clin-
ical trials for epidermolysis bullosa)
Debra of America, Inc. (Dystrophic Epidermolysis Bullosa): http://www.debra.org (has a ‘‘new parent’’ program that pro-
vides practical information about wound care, medical supplies, and medical insurance)
Dermatlas.org: http://www.dermatlas.net (an interactive dermatology atlas that can be searched by diagnosis, lesion
characteristics, patient demographics, and treatments)
EB Info World: http://blog.ebinfoworld.com (provides feeding suggestions)
EB Medical Research Foundation: http://www.ebkids.org
Epidermolysis Bullosa Action Network: http://www.ebanusa.org
Genetic and Rare Diseases (GARD) Information Center: http://rarediseases.info.nih.gov/GARD
National Epidermolysis Bullosa Society
National Institute of Arthritis and Musculoskeletal and Skin Diseases: http://www.niams.nih.gov/Health_info/
epidermolysis_Bullosa
National Institutes of Health, severe junctional EB clinical trials: prpl@cc.nih.gov; (800) 411-1222
RareConnect: www.rareconnect.org; http://www.rareconnect.org (patient-hosted online community for patients and
caregivers)
Book
Fine, J. D., & Hintner, H. (Eds.). (2009). Life with epidermolysis bullosa (EB): Etiology, diagnosis, multidisciplinary care and
therapy. New York, NY: Springer Wien.
Camps for Children With Severe Skin Conditions
Camp Wonder: http://www.csdf.org
Camp Spirit: www.campspiritcolorado.com
Camp Discovery: www.aad.org/dermatology-a-to-z/for-kids/camp-discovery
of the subtypes can range from mild to severe within squamous cell carcinoma of the skin, usually occurring
each of the main types. in the third and fourth decades of life (Uitto, McGrath,
DEB has several subtypes that display a range of clin- Rodeck, Bruckner-Tuderman, & Robinson, 2010).
ical severity, including DDEB and two forms of RDEB. These complications lead to early mortality, with an
RDEB is classified as either severe generalized (RDEB- average life span of 30 to 40 years among persons
sev gen) or RDEB generalized other (RDEB-O; with RDEB (Intong & Murrell, 2012).
Sawamura et al., 2010). In DDEB, blistering is usually Living with EB can be extremely challenging for both
less severe and localized to weight-bearing or high- patients and caretakers. Treatment focuses on manag-
friction areas such as the hands, feet, knees, and el- ing wounds, monitoring for potential disease complica-
bows; however, it can generalize to other body areas. tions, and improving overall quality of life. Bathing
RDEB is typically more generalized and severe than must be individualized, because children may benefit
DDEB. As in our patient, affected infants are typically from diluted bleach
born with widespread blistering and areas of missing baths, vinegar soaks, Treatment focuses
skin, often caused by birth trauma. Epithelial bullae for- or salt baths (Pope
on managing
mation and fragility also affect mucous membranes et al., 2012). Nonstick
such as the conjunctiva, oral mucosa, and digestive dressings must be wounds,
tract. Malformed or missing fingernails and toenails used in areas of blister monitoring for
and scarring with milia formation occur in both types formation or on skin le-
potential disease
of DEB. Our patient presented with many of these sions. Foam dressings
classic DEB features. must be used to protect complications, and
Our patient had RDEB, the most severe form of this areas of bony promi- improving overall
condition. RDEB is associated with many complica- nence that are at risk
quality of life.
tions. Repetitive blister formation and healing can of skin breakdown or
cause severe scarring and stricture formation. Patients blister formation. Par-
may experience fusion of the fingers and toes (pseudo- ents must routinely check the children’s skin and be
syndactyly), loss of fingernails and toenails, joint defor- comfortable identifying areas of potential infection.
mities (contractures) that restrict movement, and Thorough examinations of the skin surface need to be
corneal scarring with vision loss. Scarring in the mouth performed at least every 6 months by a medical profes-
and esophagus can cause difficulty with chewing and sional (dermatologist or pediatric clinician) familiar
swallowing of food, which can ultimately lead to with EB. Skin surface areas to be examined can be
chronic malnutrition and affect overall growth. It is rotated with each visit (Pope et al., 2012).
not uncommon for children with RDEB to experience Primary care providers (PCPs) serve important roles
anemia from blood loss through wounds, poor nutri- in the care of children with EB. In addition to moni-
tional intake, poor iron absorption, and bone marrow toring the growth and development of these children,
suppression from chronic inflammation. They also PCPs must screen for complications associated with
may have failure to thrive, recurrent skin infections, EB and serve as gatekeepers for the many specialty re-
renal disease, esophageal strictures, and osteoporosis. ferrals and services these children and their family
Patients with RDEB also are at increased risk for members require. PCPs can offer practical guidance